# Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics

> **NCT02052804** · — · COMPLETED · sponsor: **University of Alberta** · enrollment: 700 (estimated)

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02052804
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2015-12
- **Final completion:** 2022-05-02
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052804, "Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02052804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*